Product
MLS-101
1 clinical trial
2 indications
Indication
HypertensionIndication
RenalClinical trial
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Phase 2 Study to Evaluate the Safety, Efficacy, and Tolerability of MLS-101 in Subjects With Uncontrolled HypertensionStatus: Completed, Estimated PCD: 2022-09-07